Phytochemical Name : Rh2

Properties Information
PhytoCAT-ID PhytoCAT-1150
Phytochemical name or plant extracts Rh2
PMID 15389289
Literature evidence In the present study, we tested Rh2 on many tumor-cell lines for its effects on cell proliferation, induction of apoptosis, and potential interaction with conventional chemotherapy agents.
IUPAC name NA
Phytochemicals’ class or type of plant extracts Ginsenoside
Source of phytochemicals or plant Extracts Panax ginseng
Geographical availability Khabarovsk, Korea, Manchuria, Primorye
Plant parts Root
Other cancers Breast cancer
Target gene or protein Cyclin D3, CIP1, RNF217, RNA STXBP5-AS1
Gene or Protein evidence G-Rh2 treatment down-regulated the protein level of cyclin D3 but upregulated the expression of cyclin-dependent kinase (Cdk) inhibitor p21WAF1/CIP1. Screening the target genes of miR-4425 and Rh2 revealed that Rh2, STXBP5-AS1, and miR-4425 consistently regulated tumor suppressor RNF217 at both the RNA and protein level. Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation.
Target pathways Notably, up-regulation of STXBP5- AS1 was also observed in Rg3-treated MCF-7 cells, implicating Rh2 and Rg3 as common regulators of the STXBP5-AS1/miR-4425 pathway. Therefore, Rh2 controls the STXBP5-AS1/miR-4425/RNF217 axis to suppress breast cancer cell growth.
IC50 NA
Potency These results suggest that Rh2 possesses strong tumor-inhibiting properties, and potentially can be used in treatments for multidrug-resistant cancers, especially when it is used in combination with conventional chemotherapy agents.
Cell line/ mice model MCF-7
Additional information  The ginsenoside Rh2 has strong anti-cancer, anti-inflammatory, and anti-diabetic effects.
PubChem ID NA
Additional PMIDs 10200336 34764730
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:91472-1
Safety NA